Stand Number: 919
Book a Meeting at the Show
Arvida Labs is a leading manufacturer of rare cannabinoids. Our experienced team with doctorates in pharmaceutical sciences and chemistry have combined their expertise to formulate products using traditional and rare cannabinoid to target the endocannabinoid system to give end users a unique experience verses traditional products with a singular cannabinoid focus.
Using our patent pending processes we have shown the ability to modify the chemical structure of CBD & CBG into the following rare cannabinoids: D8, D9, D10, THCv, THC-O-Acetate, Hexahydroxycannabinol, CBND, CBC, CBN.
Some of these cannabinoids are naturally occurring in small quantities that make it nearly impossible to scale via traditional extraction, distillation, refinement.
Arvida labs has filed for multiple patents on our methods of producing these rare cannabinoids at scale, without the production of unknown isomers, at the highest purity. We are working with leading analytical labs to develop standards for some of these cannabinoids that otherwise do not have existing testing standards.